Capitalization and Commercialization Rating service (CCR) software by E-Zassi LLC, Fernandina Beach, FL, is for technology transfer agents, venture capital and angel investment groups, individual and organizational researchers, and creators of new or emerging medical technologies. The process was developed to deliver a rapid approach to triaging medical device opportunities and understanding their commercialization attractiveness and burdens. Based on content generated by the InnoVision software available on line, the medical technology is weighted against a predetermined set of business development criteria. These and other data points are algorithmically processed and aggregated into the “Capitalization and Commercialization Rating” or CCR. This CCR is depicted as a numerical score that provides the client with a comprehensive assessment of the technology’s market attractiveness and ability to attract the resources needed to development, funding, and commercialization. This business intelligence ensures that an organization’s business development and/or technology transfer efforts are correctly aligned and that the first-stage diligence process is efficient.